These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 10242281)

  • 1. Forces and direction of drug product selection legislation.
    Stewart JE
    Med Mark Media; 1979 Jun; 14(6):34-6, 38-9. PubMed ID: 10242281
    [No Abstract]   [Full Text] [Related]  

  • 2. The high price of mandatory substitution.
    Dickinson J
    Hosp Formul; 1978 Oct; 13(10):811-2. PubMed ID: 10238813
    [No Abstract]   [Full Text] [Related]  

  • 3. How many patients still get the drug you prescribe?
    Rosenberg CL
    Med Econ; 1979 Sep; 56(18):35-6, 40, 44 passim. PubMed ID: 10243615
    [No Abstract]   [Full Text] [Related]  

  • 4. Generic drug equivalents: opening Pandora's Rx.
    Regulation; 1979; 3(3):4-5. PubMed ID: 10242344
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug product selection legislation: a comparative analysis.
    Wetherbee H; Sharpe TR
    Am J Pharm Sci Support Public Health; 1978; 150(6):171-6. PubMed ID: 576098
    [No Abstract]   [Full Text] [Related]  

  • 6. Doctors are pivotal to prescription struggle.
    Chapman S
    Leg Aspects Med Pract; 1979 Mar; 7(3):42-4. PubMed ID: 423688
    [No Abstract]   [Full Text] [Related]  

  • 7. The Ohio Generic Product Selection Law: influence on pharmacy practice.
    Hunter RH
    Med Mark Media; 1979 Jul; 14(7):33-6. PubMed ID: 10243269
    [No Abstract]   [Full Text] [Related]  

  • 8. FTC: our model product selection law relies on the pharmacist's expertise.
    Holmes PD
    Pharm Times; 1979 Feb; 45(2):36-9. PubMed ID: 10240271
    [No Abstract]   [Full Text] [Related]  

  • 9. New York's generic drug substitution law.
    Kamen A
    N Y State Dent J; 1980 Nov; 46(9):599-604. PubMed ID: 6935574
    [No Abstract]   [Full Text] [Related]  

  • 10. Annual Albany College of Pharmacy prescription survey.
    DeNuzzo RV
    Med Mark Media; 1979 Apr; 14(4):15-6, 18-20, 22-5 passim. PubMed ID: 10241448
    [No Abstract]   [Full Text] [Related]  

  • 11. Prescriptions enter the political arena.
    Regier H
    J Leg Med (N Y); 1974; 2(3):26-30. PubMed ID: 4546224
    [No Abstract]   [Full Text] [Related]  

  • 12. Right to prescribe at issue in proposed "MAC" regulations.
    Ragan CA
    Med Times; 1975 Apr; 103(4):23, 25. PubMed ID: 1117829
    [No Abstract]   [Full Text] [Related]  

  • 13. Potential and actual drug product selection rates in Florida.
    Vuturo GJ; McCormick WC; Krischer JP
    Contemp Pharm Pract; 1980; 3(3):163-70. PubMed ID: 10247872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. M.D.'s update on generic.
    Kellogg N
    Leg Aspects Med Pract; 1978 May; 6(5):19-22. PubMed ID: 703469
    [No Abstract]   [Full Text] [Related]  

  • 15. Guidelines for pharmacists performing product selection.
    Am Pharm; 1990 Jul; NS30(7):40-1. PubMed ID: 2363394
    [No Abstract]   [Full Text] [Related]  

  • 16. Generic drug substitution law. Open letter from Attorney General Robert Abrams.
    Abrams R
    N Y State J Med; 1979 Jul; 79(8):1243. PubMed ID: 287925
    [No Abstract]   [Full Text] [Related]  

  • 17. Curtailment of prescribing in the National Health Service.
    Lancet; 1984 Nov; 2(8412):1136-7. PubMed ID: 6150189
    [No Abstract]   [Full Text] [Related]  

  • 18. Philosophy, prescriptions, and politics.
    Bess DR
    JAMA; 1980 Feb; 243(6):525-7. PubMed ID: 7351782
    [No Abstract]   [Full Text] [Related]  

  • 19. Substitution: expectations and realization.
    Gorrell JM
    Med Mark Media; 1981 May; 16(5):52, 54-7. PubMed ID: 10251529
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug costs can be defended.
    Lee AM
    Med Mark Media; 1982 Mar; 17(3):36, 38, 40 passim. PubMed ID: 10309584
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.